Stephanie K. DouganPhD
Stephanie Dougan received her Ph.D. in immunology from Harvard University, where she studied lipid antigen presentation by CD1d and NKT cell development with Richard Blumberg. She then performed a postdoctoral fellowship with Hidde Ploegh at Whitehead Institute, where she became adept in somatic cell nuclear transfer and embryo manipulations for the purpose of generating trans nuclear and CRISPR genome-modified mice.
Dr. Dougan joined the faculty at Harvard Medical School (HMS) and Dana-Farber Cancer Institute in 2014, where her lab uses unique mouse models to study the immune response to tumors. She is particularly interested in tumors that do not induce a CD8 T cell response at baseline and has been using pancreatic cancer as a model to develop new immunotherapies for non-T cell infiltrated tumors.
Dr. Dougan is the course director for the Harvard Immunology Summer Undergraduate Program, the co-director for the graduate school class Immunology 201, and the course director for an Advanced Integrated Science course in immunology for third-year HMS medical students.